We are live on ! Find out more
MWNA

Marshall Wace North America Portfolio holdings

AUM $23.5B
1-Year Est. Return 46.46%
This Fund
S&P 500
This Quarter Est. Return
+5.39%
1 Year Est. Return
+46.46%
3 Year Est. Return
+109.4%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$16.1B
AUM Growth
+$1.98B
Cap. Flow
+$1.34B
Cap. Flow %
8.3%
Top 10 Hldgs %
18.52%
Holding
1,899
New
351
Increased
456
Reduced
282
Closed
805

Top Buys

Rank Stock Value
1
META icon
Meta Platforms (Facebook)
META
+$260M
2
BABA icon
Alibaba
BABA
+$229M
3
GILD icon
Gilead Sciences
GILD
+$168M
4
BA icon
Boeing
BA
+$151M
5
ABT icon
Abbott
ABT
+$148M

Top Sells

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$306M
2
UNH icon
UnitedHealth
UNH
+$244M
3
VMC icon
Vulcan Materials
VMC
+$146M
4
PEP icon
PepsiCo
PEP
+$98.4M
5
ELV icon
Elevance Health
ELV
+$96.5M

Sector Composition

Rank Sector Weight
1 Healthcare 27.6%
2 Technology 15.66%
3 Consumer Discretionary 13.93%
4 Industrials 11.16%
5 Communication Services 8.05%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
DOO
201
Bombardier Recreational Products
DOO
$4.68B
$13.5M 0.08%
376,418
-18,998
-5% -$591K
BRK.A icon
202
Berkshire Hathaway Class A
BRK.A
$1.13T
$13.4M 0.08%
42
+41
+4,100% +$12.7M
SBUX icon
203
Starbucks
SBUX
$120B
$13.3M 0.08%
158,058
-499,386
-76% -$39.2M
CROX icon
204
Crocs
CROX
$6.43B
$13.2M 0.08%
670,698
+215,100
+47% +$4.98M
MSI icon
205
Motorola Solutions
MSI
$78.7B
$13.2M 0.08%
79,409
-46,744
-37% -$7.04M
ALNY icon
206
Alnylam Pharmaceuticals
ALNY
$28.9B
$13.2M 0.08%
+181,395
New +$13.9M
WM icon
207
Waste Management
WM
$91.5B
$13.1M 0.08%
113,581
+54,561
+92% +$5.92M
MNST icon
208
Monster Beverage
MNST
$92.1B
$13M 0.08%
407,264
-121,316
-23% -$3.66M
KEYS icon
209
Keysight
KEYS
$57.6B
$12.6M 0.08%
140,279
+118,727
+551% +$10.1M
RHI icon
210
Robert Half
RHI
$4.16B
$12.5M 0.08%
219,337
+158,124
+258% +$9.44M
LUMN icon
211
Lumen
LUMN
$6.09B
$12.4M 0.08%
1,051,027
+1,020,354
+3,327% +$11.5M
G icon
212
Genpact
G
$6.13B
$12.2M 0.08%
319,897
-25,201
-7% -$917K
ENB icon
213
Enbridge
ENB
$113B
$12.2M 0.08%
336,417
+274,117
+440% +$9.98M
VAR
214
DELISTED
Varian Medical Systems, Inc.
VAR
$12.1M 0.07%
88,694
-41,772
-32% -$5.58M
RRR icon
215
Red Rock Resorts
RRR
$3.68B
$11.8M 0.07%
550,438
+408,329
+287% +$9.92M
BDX icon
216
Becton Dickinson
BDX
$48.8B
$11.5M 0.07%
46,871
-371,195
-89% -$86.2M
OGS icon
217
ONE Gas
OGS
$5B
$11.5M 0.07%
127,478
-500
-0.4% -$44.2K
BBY icon
218
Best Buy
BBY
$16.9B
$11.4M 0.07%
163,126
+67,605
+71% +$4.72M
NOC icon
219
Northrop Grumman
NOC
$80.7B
$11.3M 0.07%
34,825
+21,632
+164% +$6.45M
CLR
220
DELISTED
CONTINENTAL RESOURCES INC.
CLR
$11M 0.07%
260,941
+199,968
+328% +$8.54M
ZEN
221
DELISTED
ZENDESK INC
ZEN
$11M 0.07%
123,131
-131,819
-52% -$11.3M
PTR
222
DELISTED
PETROCHINA COMPANY LIMITED ADS (REP 100 H SHARES)
PTR
$11M 0.07%
198,850
+72,214
+57% +$4.33M
EHC icon
223
Encompass Health
EHC
$12.4B
$10.9M 0.07%
215,387
+201,770
+1,482% +$9.79M
SKYW icon
224
Skywest
SKYW
$4.4B
$10.9M 0.07%
178,924
-56,505
-24% -$3.35M
AVNT icon
225
Avient
AVNT
$3.91B
$10.8M 0.07%
343,515
+341,304
+15,437% +$9.56M
7 8
9
10 11

Similar funds

TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
PAM
PFM Asset Management Harrisburg, Pennsylvania $5.36B AUM 21.04% 1-Year Est. Return
HB
Homrich & Berg Atlanta, Georgia $4.47B AUM 22.61% 1-Year Est. Return
MWA
Marshall Wace Asia Central, Hong Kong $4.23B AUM 69.9% 1-Year Est. Return
3SCA
36 South Capital Advisors London, United Kingdom $3.76B AUM
HFCIV
H&F Corporate Investors VII San Francisco, California $3.61B AUM 26.49% 1-Year Est. Return
DVC
Deer VIII & Co Larchmont, New York $3.56B AUM
NAM
NorthCoast Asset Management Greenwich, Connecticut $2.74B AUM 25.44% 1-Year Est. Return

Marshall Wace North America's Q2 2019 Portfolio in Review

As of Q2 2019, Marshall Wace North America held 1,899 positions worth $16.1B, up 14% from $14.1B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Marshall Wace North America deployed $1.34B of net new capital in Q2 2019, opening 351 new positions and adding to 456 existing holdings. Its largest new stake was Abbott: 1,884,363 shares worth $158M.

By sector, the portfolio is most concentrated in Healthcare at 28% of assets, down from 32% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Pfizer, an estimated $306M trimmed.

  • Marshall Wace North America's largest Q2 2019 buy was Abbott: 1,884,363 shares worth $158M.
  • Marshall Wace North America added most to Meta Platforms (Facebook) in Q2 2019, an estimated $260M increase.
  • Marshall Wace North America's biggest Q2 2019 reduction was Pfizer, cutting an estimated $306M.
  • Marshall Wace North America fully exited UnitedHealth in Q2 2019, selling an estimated $244M.
  • Marshall Wace North America's ten largest holdings make up 19% of its $16.1B portfolio in Q2 2019.
  • Marshall Wace North America opened 351 new positions and closed 805 in Q2 2019.
  • Marshall Wace North America's portfolio value rose 14% quarter-over-quarter to $16.1B.

Based on Marshall Wace North America's 13F filing for Q2 2019, filed 14 Aug 2019.